Oversea-Chinese Banking Corp (OCBC)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.74M Sell
31,129
-14,832
-32% -$1.71M 0.1% 143
2025
Q4
$4.84M Sell
45,961
-20,168
-30% -$1.89M 0.13% 105
2025
Q3
$5.46M Sell
66,129
-13,844
-17% -$1.14M 0.13% 102
2025
Q2
$6.32M Sell
79,973
-58,330
-42% -$4.64M 0.17% 91
2025
Q1
$12.4M Buy
138,303
+17,658
+15% +$1.65M 0.35% 61
2024
Q4
$12M Buy
120,645
+33,845
+39% +$3.49M 0.34% 62
2024
Q3
$9.85M Sell
86,800
-22,372
-20% -$2.66M 0.27% 72
2024
Q2
$13.5M Sell
109,172
-138,938
-56% -$17.9M 0.4% 57
2024
Q1
$32.7M Sell
248,110
-98,748
-28% -$12.2M 0.98% 26
2023
Q4
$37.8M Buy
346,858
+18,333
+6% +$1.9M 1.33% 18
2023
Q3
$33.8M Buy
328,525
+41,123
+14% +$4.43M 1.53% 13
2023
Q2
$33.2M Sell
287,402
-48,193
-14% -$5.47M 1.59% 13
2023
Q1
$35.7M Sell
335,595
-24,036
-7% -$2.6M 1.78% 13
2022
Q4
$39.9M Buy
+359,631
New +$36.8M 2.3% 10

Other funds holding MRK

Oversea-Chinese Banking Corp (OCBC)'s MRK Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) reduced its Merck (MRK) stake by 32% in Q1 2026, selling an estimated $1.71M and leaving 31,129 shares worth $3.74M. The position accounts for 0.1% of the portfolio, ranked #143.

Oversea-Chinese Banking Corp (OCBC) first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $39.9M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 31,129 shares of Merck worth $3.74M as of Q1 2026.
  • Oversea-Chinese Banking Corp (OCBC) sold 14,832 Merck shares in Q1 2026, an estimated $1.71M.
  • Merck made up 0.1% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q1 2026, its #143 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s Merck position peaked at $39.9M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.